• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射疗法。

Radiotherapy.

作者信息

Krause Sonja, Debus Jürgen, Neuhof Dirk

机构信息

Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany.

出版信息

Recent Results Cancer Res. 2011;183:285-91. doi: 10.1007/978-3-540-85772-3_13.

DOI:10.1007/978-3-540-85772-3_13
PMID:21509690
Abstract

Solitary plasmocytoma occurring in bone (solitary plasmocytoma of the bone, SBP) or in soft tissue (extramedullary plasmocytoma, EP) can be treated effectively and with little toxicity by local radiotherapy. Ten-year local control rates of up to 90% can be achieved. Patients with multiple myeloma often suffer from symptoms such as pain or neurological impairments that are amenable to palliative radiotherapy. In a palliative setting, short treatment schedules and lower radiation doses are used to reduce toxicity and duration of hospitalization. In future, low-dose total body irradiation (TBI) may play a role in a potentially curative regimen with nonmyeloablative conditioning followed by allogenic peripheral blood stem cell transplantation.

摘要

发生于骨的孤立性浆细胞瘤(骨孤立性浆细胞瘤,SBP)或软组织的孤立性浆细胞瘤(髓外浆细胞瘤,EP),通过局部放疗可得到有效治疗,且毒性较小。十年局部控制率可达90%。多发性骨髓瘤患者常出现疼痛或神经功能障碍等症状,适合进行姑息性放疗。在姑息治疗中,采用短疗程和较低辐射剂量以降低毒性和缩短住院时间。未来,低剂量全身照射(TBI)可能在一种潜在的治愈方案中发挥作用,该方案采用非清髓性预处理,随后进行异基因外周血干细胞移植。

相似文献

1
Radiotherapy.放射疗法。
Recent Results Cancer Res. 2011;183:285-91. doi: 10.1007/978-3-540-85772-3_13.
2
Radiotherapy in the management of plasma cell tumors.放射治疗在浆细胞肿瘤管理中的应用
Oncology (Williston Park). 2000 Jan;14(1):101-8, 111; discussion 111-2, 115.
3
[Radiotherapy for myeloma].
Nihon Rinsho. 1995 Mar;53(3):653-7.
4
Radiotherapy of solitary plasmacytoma.单发浆细胞瘤的放射治疗。
Ann Hematol. 2011 Sep;90(9):1093-7. doi: 10.1007/s00277-011-1190-7. Epub 2011 Feb 19.
5
[Radiotherapy for solitary plasmacytoma and multiple myeloma].[孤立性浆细胞瘤和多发性骨髓瘤的放射治疗]
Radiologe. 2014 Jun;54(6):551-5. doi: 10.1007/s00117-013-2630-2.
6
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.孤立性浆细胞瘤和多发性骨髓瘤的放射治疗:国际淋巴瘤放射肿瘤学组指南。
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):794-808. doi: 10.1016/j.ijrobp.2018.05.009. Epub 2018 Jun 20.
7
[Indications for and results of radiotherapy of plasmacytomas].
Radiobiol Radiother (Berl). 1990;31(3):231-7.
8
Radiation therapy in multiple myeloma.多发性骨髓瘤的放射治疗。
Radiology. 1975 Apr;115(1):175-8. doi: 10.1148/115.1.175.
9
[Four cases of an extramedullary plasmacytoma of the head and neck].[四例头颈部髓外浆细胞瘤]
Gan No Rinsho. 1990 Jan;36(1):81-6.
10
[Benefits of radiotherapy for patients with solitary plasmacytoma or multiple myeloma].[放射治疗对孤立性浆细胞瘤或多发性骨髓瘤患者的益处]
Radiologe. 2022 Jan;62(1):30-34. doi: 10.1007/s00117-021-00935-y. Epub 2021 Nov 11.

引用本文的文献

1
Risk factor analysis of dental implants in patients with irradiated head and neck cancer.头颈部放疗后患者行牙种植术的风险因素分析。
Head Neck. 2022 Aug;44(8):1816-1824. doi: 10.1002/hed.27080. Epub 2022 May 12.
2
Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment.靶向S100A4的小干扰RNA使非小细胞肺癌细胞(A549)对放射治疗敏感。
Onco Targets Ther. 2016 Jun 23;9:3753-62. doi: 10.2147/OTT.S106557. eCollection 2016.
3
How to improve the survival rate of implants after radiotherapy for head and neck cancer?
如何提高头颈部癌放疗后植入物的存活率?
J Periodontal Implant Sci. 2014 Feb;44(1):2-7. doi: 10.5051/jpis.2014.44.1.2. Epub 2014 Feb 26.
4
Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells.细胞分裂周期蛋白 25C 同源物 c 对 A549 细胞低剂量超放射敏感性和高剂量诱导放射抗性的影响。
J Radiat Res. 2012 Sep;53(5):686-94. doi: 10.1093/jrr/rrs024. Epub 2012 Jun 6.